MARY FISHER
CIK 1272360 · Chief Operating Officer · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.1K
Companies
6
Total Filings
55
Lifetime Open-Market Net
-$3.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DRMAW | Director | 196,946 | $0.01 | $2.1K | $0 | 9 | 2026-01-06 |
| Sientra, Inc. (SIEN) Delisted | Director | 19,581 | $0.17 | $3.4K | $0 | 6 | 2023-06-20 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | 221 | $15.90 | $3.5K | $0 | 1 | 2018-12-11 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 2,964 | — | — | $100.6K | 21 | 2018-10-02 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 0 | — | — | -$2.65M | 9 | 2017-04-28 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Chief Operating Officer | 499 | $0.66 | $330 | -$1.01M | 9 | 2007-07-05 |
Recent Filings · Page 2 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-17 | DRMAW | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +16,870 | $0 | EDGAR |
| 2020-06-09 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +27,717 | $0 | EDGAR |
| 2019-06-18 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +19,320 | $0 | EDGAR |
| 2019-01-10 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +11,934 | $151.7K | EDGAR |
| 2018-12-11 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | +355 | $0 | EDGAR |
| 2018-10-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +6,851 | $0 | EDGAR |
| 2018-07-06 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +5,510 | $0 | EDGAR |
| 2018-04-03 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +6,165 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.